// App-Quantinova.ai

PB1372 : Rivaroxaban in patients with intestinal failure on parenteral nutrition (TINCRBEL study)

Researchers

Presenter

  • T. van Haaps

Principal Investigators

  • R. Bavalia

  • R. Matht

  • S. Middeldorp

  • M. Coppens

Medical Centers

  • Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Amsterdam, Noord-Holland, Netherlands

  • Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Noord-Holland, Netherlands

  • Department of Hospital Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands, Amsterdam, Noord-Holland, Netherlands

  • Department of Hospital Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands, Amsterdam, Noord-Holland, Netherlands

  • Radboud U university medical center, Nijmegen, Gelderland, Netherlands

  • Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Amsterdam, Noord-Holland, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Gastroenterology (GU)

Disease

  • Short bowel syndrome

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved